Appendix A: Pediatric Antiretroviral Drug Information

Overview

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)

Abacavir
Emtricitabine
Lamivudine
Tenofovir alafenamide
Tenofovir disoproxil fumarate
Zidovudine

Non-Nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs)

Doravirine
Efavirenz
Etravirine
Nevirapine
Rilpivirine

Protease Inhibitors (PIs)

Atazanavir
Darunavir
Lopinavir/Ritonavir

Entry and Fusion Inhibitors

Ibalizumab
Maraviroc

Integrase Inhibitors (INSTIs)

Bictegravir
Dolutegravir
Elvitegravir
Raltegravir

Pharmacokinetic Enhancers

Cobicistat
Ritonavir

Fixed-Dose Combinations

Antiretrovirals Available in Fixed-Dose Combination Tablets
Antiretroviral Fixed-Dose Combination Tablets: Minimum Body Weights and Considerations for Use in Children and Adolescents

Archived Drugs

Didanosine
Enfuvirtide
Fosamprenavir
Indinavir
Nelfinavir
Saquinavir
Stavudine
Tipranavir

Updated
Reviewed
Aug. 18, 2020

Download Guidelines